EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSPREG00000020942
Gene Symbol: DHCR24
3 Cross references
208 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11b

Ensembl ID : ENSPREG00000012686
Gene Symbol: LOC103481710
3 Cross references
220 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4

Ensembl ID : ENSPREG00000020043
Gene Symbol: LOC103472718
3 Cross references
226 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4-Like

Ensembl ID : ENSPREG00000016628
Gene Symbol: LOC103478144
3 Cross references
220 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSPREG00000012276
Gene Symbol: HMGCR
3 Cross references
195 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase

Ensembl ID : ENSPREG00000018525
Gene Symbol: LOC103473284
3 Cross references
205 Possible Orthologues:

3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2

Ensembl ID : ENSPREG00000007236
Gene Symbol: LOC103477241
3 Cross references
191 Possible Orthologues:

3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2-Like

Ensembl ID : ENSPREG00000005061
Gene Symbol: LOC103471931
3 Cross references
208 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSPREG00000017813
Gene Symbol: PDPK1
3 Cross references
221 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase-Like

Ensembl ID : ENSPREG00000010476
Gene Symbol: LOC103470603
3 Cross references
204 Possible Orthologues:

40s Ribosomal Protein S19

Ensembl ID : ENSPREG00000004800
Gene Symbol: LOC103477840
3 Cross references
308 Possible Orthologues:

40s Ribosomal Protein S4

Ensembl ID : ENSPREG00000005808
Gene Symbol: LOC103480264
3 Cross references
495 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).